These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32328391)

  • 1. Bilateral Pneumonia in a Patient with Chronic Bronchiectasis Caused by Achromobacter xylosoxidans Subspecies denitrificans.
    Stepman G; Dabb K; Khan IA; Young JT; Frunzi J
    Cureus; 2020 Mar; 12(3):e7381. PubMed ID: 32328391
    [No Abstract]   [Full Text] [Related]  

  • 2. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonia due to a Rare Pathogen:
    Awadh H; Mansour M; Aqtash O; Shweihat Y
    Case Rep Infect Dis; 2017; 2017():3969682. PubMed ID: 28894613
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case of Phage Therapy against Pandrug-Resistant
    Lebeaux D; Merabishvili M; Caudron E; Lannoy D; Van Simaey L; Duyvejonck H; Guillemain R; Thumerelle C; Podglajen I; Compain F; Kassis N; Mainardi JL; Wittmann J; Rohde C; Pirnay JP; Dufour N; Vermeulen S; Gansemans Y; Van Nieuwerburgh F; Vaneechoutte M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 6. Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge.
    Batool A; Chaudhry S; Batool K; Omar MA
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38195188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
    Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meropenem-Resistant Achromobacter xylosoxidans, Subspecies Denitrificans Bacteremia in a Patient With Stage IV Adenocarcinoma of the Lung.
    Agassi AM; Pollock E; Carter MM; Sherertz RJ; Mangano AP
    Cureus; 2021 Jun; 13(6):e15546. PubMed ID: 34277171
    [No Abstract]   [Full Text] [Related]  

  • 9. Achromobacter xylosoxidans Purulent Bronchitis in a Previously Healthy Child: An Unexpected Consequence of COVID-19 Infection.
    Matijasic N; Tripalo Batos A; Lenicek Krleza J; Rogulj M; Pavic I
    Cureus; 2022 Jan; 14(1):e21711. PubMed ID: 35242477
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Bates AS; Natarajan M; Reddy RV
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case.
    Roy P
    J Clin Diagn Res; 2014 May; 8(5):DD01-2. PubMed ID: 24995184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.
    Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M
    Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the
    Le Goff M; Vastel M; Lebrun R; Mansuelle P; Diarra A; Grandjean T; Triponney P; Imbert G; Gosset P; Dessein R; Garnier F; Durand E
    Front Cell Infect Microbiol; 2022; 12():859181. PubMed ID: 35782124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Pickrum AM; Riegert MO; Wells C; Brockman K; Frank DW
    Microbiol Spectr; 2022 Aug; 10(4):e0208322. PubMed ID: 35856670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exoproducts of the Most Common
    Sahl C; Baumgarten M; Shannon O; Påhlman LI
    Microbiol Spectr; 2023 Aug; 11(4):e0019523. PubMed ID: 37284754
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.
    Firmida MC; Pereira RH; Silva EA; Marques EA; Lopes AJ
    Braz J Med Biol Res; 2016; 49(4):e5097. PubMed ID: 26909788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.
    Trancassini M; Iebba V; Citerà N; Tuccio V; Magni A; Varesi P; De Biase RV; Totino V; Santangelo F; Gagliardi A; Schippa S
    Front Microbiol; 2014; 5():138. PubMed ID: 24772108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial Achromobacter xylosoxidans Infection Presenting as a Cavitary Lung Lesion in a Lung Cancer Patient.
    Sebanayagam V; Nguyen P; Nassar M; Soubani A
    Cureus; 2020 Aug; 12(8):e9818. PubMed ID: 32953328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.